Convince

To Reduce the risk of another stroke patients are randomized to usual care or low dose Colchicine.

Colchicine for prevention of vascular inflammation in Non-Cardioembolic Stroke

Key Eligibility Criteria

Ischemic Stroke within 28 days

Therapeutic Area

Stroke

Type of Study

Clinical trial

Sponsor

UCD

Principal Investigator

Dr Tim Cassidy

Contact

Edel.meaney@ucd.ie